Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Cunbing Xia

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5047363598. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers

Papers 4

  1. Ultrasound-Mediated Modulation of circRNA hsa_circ_0004870 as a Prognostic and Therapeutic Biomarker in Pancreatic Cancer. Co-author DOI 10.1177/10849785251412134↗
  2. Circular RNA hsa_circ_0003472 Promotes Pancreatic Ductal Adenocarcinoma Progression and Gemcitabine Resistance Via the mir-1253/ERCC1 Axis. Co-author DOI 10.1186/s12575-026-00335-3↗
  3. Immune response and drug therapy based on ac4C-modified gene in pancreatic cancer typing. Co-author DOI 10.3389/fimmu.2023.1133166↗
  4. Identification of Molecular Targets and Underlying Mechanisms of Xiaoji Recipe against Pancreatic Cancer Based on Network Pharmacology. Co-author DOI 10.1155/2022/4640849↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yongkang Zhu · 3 shared papers, 2022–2026 · strength 0.72
  2. Hongbao Yang · 2 shared papers, 2022–2023 · strength 0.36
  3. Chunyang Lv · 1 shared paper, 2026 · strength 0.29
  4. Hong Zhu · 1 shared paper, 2026 · strength 0.29
  5. Yang Chen · 1 shared paper, 2023 · strength 0.22
  6. Dong Xu · 1 shared paper, 2023 · strength 0.22
  7. Hong Zhu · 1 shared paper, 2022 · strength 0.14
  8. Dong Xu · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.